In contrast, Ross et al.44 showed that the most frequent genomic alteration was in P53 (55%) followed by Breast Cancer susceptibility gene (BRCA2) (6%), after comprehensive genomic profiling of 200 patients with CUP. This evidence concerns the gene TP53 and breast carcinoma.